1. Home
  2. CDNA vs LGIH Comparison

CDNA vs LGIH Comparison

Compare CDNA & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • LGIH
  • Stock Information
  • Founded
  • CDNA 1998
  • LGIH 2003
  • Country
  • CDNA United States
  • LGIH United States
  • Employees
  • CDNA N/A
  • LGIH N/A
  • Industry
  • CDNA Medical Specialities
  • LGIH Homebuilding
  • Sector
  • CDNA Health Care
  • LGIH Consumer Discretionary
  • Exchange
  • CDNA Nasdaq
  • LGIH Nasdaq
  • Market Cap
  • CDNA 1.0B
  • LGIH 1.2B
  • IPO Year
  • CDNA 2014
  • LGIH 2013
  • Fundamental
  • Price
  • CDNA $12.92
  • LGIH $58.91
  • Analyst Decision
  • CDNA Buy
  • LGIH Hold
  • Analyst Count
  • CDNA 6
  • LGIH 5
  • Target Price
  • CDNA $29.33
  • LGIH $84.00
  • AVG Volume (30 Days)
  • CDNA 2.1M
  • LGIH 374.4K
  • Earning Date
  • CDNA 07-30-2025
  • LGIH 08-05-2025
  • Dividend Yield
  • CDNA N/A
  • LGIH N/A
  • EPS Growth
  • CDNA N/A
  • LGIH N/A
  • EPS
  • CDNA 1.07
  • LGIH 7.76
  • Revenue
  • CDNA $346,421,000.00
  • LGIH $2,163,167,000.00
  • Revenue This Year
  • CDNA $13.31
  • LGIH N/A
  • Revenue Next Year
  • CDNA $15.46
  • LGIH $27.68
  • P/E Ratio
  • CDNA $12.11
  • LGIH $7.62
  • Revenue Growth
  • CDNA 25.92
  • LGIH N/A
  • 52 Week Low
  • CDNA $10.96
  • LGIH $47.17
  • 52 Week High
  • CDNA $34.84
  • LGIH $125.83
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 28.64
  • LGIH 55.96
  • Support Level
  • CDNA $11.62
  • LGIH $50.36
  • Resistance Level
  • CDNA $13.15
  • LGIH $53.00
  • Average True Range (ATR)
  • CDNA 1.36
  • LGIH 2.53
  • MACD
  • CDNA -0.91
  • LGIH -0.01
  • Stochastic Oscillator
  • CDNA 18.04
  • LGIH 64.00

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

Share on Social Networks: